Literature DB >> 26339374

MicroRNA-539 suppresses osteosarcoma cell invasion and migration in vitro and targeting Matrix metallopeptidase-8.

Hui Jin1, Wenbo Wang1.   

Abstract

MicroRNAs (miRNA) are a class of small, non-coding RNA that involved in different cancer-related processes. Previous studies have been indicated miR-539 as a tumor suppressor during tumorigenesis. However, the role of miR-539 in osteosarcoma is still unclear. In this study, we demonstrate miR-539 was downregulated in osteosarcoma tissues compared to adjacent normal tissue. Functional study suggests miR-539 inhabits the osteosarcoma cell proliferation, invasion and migration. We also identified that MMP8 was a direct target of miR-539 by the luciferase activity assay. These findings provide evidence that miR-539 plays a key role in inhibiting osteosarcoma cell invasion and migration and can regulating MMP8 expression in osteosarcoma cells. These strongly suggest that exogenous miR-539 may have therapeutic value in treating osteosarcoma.

Entities:  

Keywords:  Matrix metallopeptidase-8 (MMP-8); miR-539; microRNA (miRNA); osteosarcoma

Mesh:

Substances:

Year:  2015        PMID: 26339374      PMCID: PMC4555702     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  22 in total

1.  Intraplaque MMP-8 levels are increased in asymptomatic patients with carotid plaque progression on ultrasound.

Authors:  Marta Miguel Turu; Jerzy Krupinski; Esther Catena; Ana Rosell; Joan Montaner; Francisco Rubio; Jose Alvarez-Sabin; Marc Cairols; Lina Badimon
Journal:  Atherosclerosis       Date:  2005-11-02       Impact factor: 5.162

2.  MicroRNA-539 is up-regulated in failing heart, and suppresses O-GlcNAcase expression.

Authors:  Senthilkumar Muthusamy; Angelica M DeMartino; Lewis J Watson; Kenneth R Brittian; Ayesha Zafir; Sujith Dassanayaka; Kyung U Hong; Steven P Jones
Journal:  J Biol Chem       Date:  2014-09-02       Impact factor: 5.157

3.  miR-26b inhibits proliferation, migration, invasion and apoptosis induction via the downregulation of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase-3 driven glycolysis in osteosarcoma cells.

Authors:  Jing-Yu Du; Li-Feng Wang; Quan Wang; Lie-Dao Yu
Journal:  Oncol Rep       Date:  2015-02-12       Impact factor: 3.906

4.  miRNA signatures associate with pathogenesis and progression of osteosarcoma.

Authors:  Kevin B Jones; Zaidoun Salah; Sara Del Mare; Marco Galasso; Eugenio Gaudio; Gerard J Nuovo; Francesca Lovat; Kimberly LeBlanc; Jeff Palatini; R Lor Randall; Stefano Volinia; Gary S Stein; Carlo M Croce; Jane B Lian; Rami I Aqeilan
Journal:  Cancer Res       Date:  2012-02-20       Impact factor: 12.701

5.  Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers.

Authors:  George Adrian Calin; Cinzia Sevignani; Calin Dan Dumitru; Terry Hyslop; Evan Noch; Sai Yendamuri; Masayoshi Shimizu; Sashi Rattan; Florencia Bullrich; Massimo Negrini; Carlo M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-18       Impact factor: 11.205

6.  Analysis of the matrix metalloproteinase family reveals that MMP8 is often mutated in melanoma.

Authors:  Lavanya H Palavalli; Todd D Prickett; John R Wunderlich; Xiaomu Wei; Allison S Burrell; Patricia Porter-Gill; Sean Davis; Chenwei Wang; Julia C Cronin; Neena S Agrawal; Jimmy C Lin; Wendy Westbroek; Shelley Hoogstraten-Miller; Alfredo A Molinolo; Patricia Fetsch; Armando C Filie; Michael P O'Connell; Carolyn E Banister; Jason D Howard; Phillip Buckhaults; Ashani T Weeraratna; Lawrence C Brody; Steven A Rosenberg; Yardena Samuels
Journal:  Nat Genet       Date:  2009-03-29       Impact factor: 38.330

7.  Osteosarcoma incidence and survival rates from 1973 to 2004: data from the Surveillance, Epidemiology, and End Results Program.

Authors:  Lisa Mirabello; Rebecca J Troisi; Sharon A Savage
Journal:  Cancer       Date:  2009-04-01       Impact factor: 6.860

8.  Long-term survivals of stage IIb osteosarcoma: a 20-year experience in a single institution.

Authors:  Yool Cho; Gu-Hee Jung; So-Hak Chung; Ji-Yeon Kim; Young Choi; Jae-Do Kim
Journal:  Clin Orthop Surg       Date:  2011-02-15

9.  Functional role of matrix metalloproteinase-8 in stem/progenitor cell migration and their recruitment into atherosclerotic lesions.

Authors:  Qingzhong Xiao; Feng Zhang; Luyang Lin; Changcun Fang; Guanmei Wen; Tsung-Neng Tsai; Xiangyuan Pu; David Sims; Zhongyi Zhang; Xiaoke Yin; Binia Thomaszewski; Boris Schmidt; Manuel Mayr; Ken Suzuki; Qingbo Xu; Shu Ye
Journal:  Circ Res       Date:  2012-10-15       Impact factor: 17.367

10.  The sequence structures of human microRNA molecules and their implications.

Authors:  Zhide Fang; Ruofei Du; Andrea Edwards; Erik K Flemington; Kun Zhang
Journal:  PLoS One       Date:  2013-01-18       Impact factor: 3.240

View more
  17 in total

Review 1.  miRNA signatures in childhood sarcomas and their clinical implications.

Authors:  G M Viera; K B Salomao; G R de Sousa; M Baroni; L E A Delsin; J A Pezuk; M S Brassesco
Journal:  Clin Transl Oncol       Date:  2019-04-04       Impact factor: 3.405

Review 2.  Emerging roles of non-coding RNAs in the pathogenesis, diagnosis and prognosis of osteosarcoma.

Authors:  Chongchong Wang; Juehua Jing; Li Cheng
Journal:  Invest New Drugs       Date:  2018-08-06       Impact factor: 3.850

3.  Long noncoding RNA LINC00339 promotes the oncogenicity of gastric cancer by regulating SRY-box 9 expression via sponging of microRNA-539.

Authors:  Hui Zhao; Hongyu Xiao; Yi Lu; Shen Liu; Cheng Wang
Journal:  Cell Cycle       Date:  2020-04-19       Impact factor: 4.534

4.  MicroRNA-539 inhibits colorectal cancer progression by directly targeting SOX4.

Authors:  Jian Zhao; Jian Xu; Rui Zhang
Journal:  Oncol Lett       Date:  2018-06-04       Impact factor: 2.967

5.  MicroRNA‑643 regulates the expression of ZEB1 and inhibits tumorigenesis in osteosarcoma.

Authors:  Huan Wang; Danmou Xing; Dong Ren; Wei Feng; Yan Chen; Zhiming Zhao; Zhihong Xiao; Zhengren Peng
Journal:  Mol Med Rep       Date:  2017-08-17       Impact factor: 3.423

6.  Long Non-coding RNA LINC00339 Stimulates Glioma Vasculogenic Mimicry Formation by Regulating the miR-539-5p/TWIST1/MMPs Axis.

Authors:  Junqing Guo; Heng Cai; Xiaobai Liu; Jian Zheng; Yunhui Liu; Wei Gong; Jiajia Chen; Zhuo Xi; Yixue Xue
Journal:  Mol Ther Nucleic Acids       Date:  2017-11-26       Impact factor: 8.886

7.  MMP8 polymorphism is associated with susceptibility to osteonecrosis of the femoral head in a Chinese Han population.

Authors:  Feimeng An; Jieli Du; Yuju Cao; Jianping Shi; Yongchang Guo; Tianbo Jin; Jian Li; Junyu Chen; Ping Li; Mei Dong; Guoqiang Wang; Jianzhong Wang
Journal:  Oncotarget       Date:  2017-03-28

8.  miR‑539 suppresses proliferation and induces apoptosis in renal cell carcinoma by targeting high mobility group A2.

Authors:  Zhi-Hua Ye; Ding-Wen Gui
Journal:  Mol Med Rep       Date:  2018-02-08       Impact factor: 2.952

9.  The Role of MMP8 in Cancer: A Systematic Review.

Authors:  Krista Juurikka; Georgina S Butler; Tuula Salo; Pia Nyberg; Pirjo Åström
Journal:  Int J Mol Sci       Date:  2019-09-11       Impact factor: 5.923

10.  miR-539 inhibits prostate cancer progression by directly targeting SPAG5.

Authors:  Hongtuan Zhang; Shadan Li; Xiong Yang; Baomin Qiao; Zhihong Zhang; Yong Xu
Journal:  J Exp Clin Cancer Res       Date:  2016-04-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.